The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Agrin and microvascular damage in Alzheimer’s disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628
Synaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432
Research works printed but not linked: 41
- Barber, 1997, Agrin accumulates in the brain microvascular basal lamina during development of the blood-brain barrier, Dev Dyn, 208, 62, 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-# · DOI
- Bowe, 1995, The role of agrin in synapse formation, Annu Rev Neurosci, 18, 443, 10.1146/annurev.ne.18.030195.002303 · DOI · Paper page
- Bowen, 1996, Neural agrin activates a high-affinity receptor in C2 muscle cells that is unresponsive to muscle agrin, J Neurosci, 16, 3791, 10.1523/JNEUROSCI.16-12-03791.1996 · DOI
- Buee, 1997, Brain microvascular changes in Alzheimer’s disease and other dementias, Ann N Y Acad Sci, 826, 7, 10.1111/j.1749-6632.1997.tb48457.x · DOI · Paper page
- Campagna, 1997, Evidence that agrin directly influences presynaptic differentiation at neuromuscular junctions in vitro, Eur J Neurosci, 9, 2269, 10.1111/j.1460-9568.1997.tb01645.x · DOI
- Castillo, 1997, Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer’s disease, accelerates A beta fibril formation, and maintains A beta fibril stability, J Neurochem, 69, 2452, 10.1046/j.1471-4159.1997.69062452.x · DOI · Paper page
- Cohen, 1997, Expression of agrin in the developing and adult rat brain, Neuroscience, 76, 581, 10.1016/S0306-4522(96)00345-4 · DOI
- de la Torre JC. Hemodynamic consequences of deformed microvessels in the brain in Alzheimer’s disease. Ann N Y Acad Sci 1997;26:826:75–91. · DOI
- Denzer, 1997, Agrin binds to the nerve-muscle basal lamina via laminin, J Cell Biol, 137, 671, 10.1083/jcb.137.3.671 · DOI · Paper page
- Donahue, 1999, Agrin in Alzheimer’s disease, Proc Natl Acad Sci U S A, 96, 6468, 10.1073/pnas.96.11.6468 · DOI
- Ferns, 1992, RNA splicing regulates agrin-mediated acetylcholine receptor clustering activity on cultured myotubes, Neuron, 8, 1079, 10.1016/0896-6273(92)90129-2 · DOI · Paper page
- Garcia, 1983, Factor VIII-related antigen in cerebrospinal fluid, Thromb Haemost, 49, 142, 10.1055/s-0038-1657340 · doi:10.1055/s-0038-1657340
- Geddes, 1985, Plasticity of hippocampal circuitry in Alzheimer’s disease, Science, 230, 1179, 10.1126/science.4071042 · DOI · Paper page
- Halfter, 1993, A heparan sulfate proteoglycan in developing avian axonal tracts, J Neurosci, 13, 2863, 10.1523/JNEUROSCI.13-07-02863.1993 · DOI
- Halfter, 1997, Distribution and substrate properties of agrin, a heparan sulfate proteoglycan of developing axonal pathways, J Comp Neurol, 383, 1, 10.1002/(SICI)1096-9861(19970623)383:1<1::AID-CNE1>3.0.CO;2-5 · doi:10.1002/(sici)1096-9861(19970623)383:1<1::aid-cne1>3.0.co;2-5
- Halfter, 1998, Collagen XVIII is a basement membrane heparan sulfate proteoglycan, J Biol Chem, 273, 25404, 10.1074/jbc.273.39.25404 · DOI · Paper page
- Hilgenberg, 1999, Evidence of an agrin receptor in cortical neurons, J Neurosci, 19, 7384, 10.1523/JNEUROSCI.19-17-07384.1999 · DOI
- Hoch, 1993, Developmental regulation of highly active alternatively spliced forms of agrin, Neuron, 11, 479, 10.1016/0896-6273(93)90152-H · DOI · Paper page
- Kalman, 1998, Increased apolipoprotein E4 allele frequency is associated with vascular dementia in the Hungarian population, Acta Neurol Scand, 98, 166, 10.1111/j.1600-0404.1998.tb07288.x · DOI
- Kroger, 1996, The developing avian retina expresses agrin isoforms during synaptogenesis, J Neurobiol, 29, 165, 10.1002/(SICI)1097-4695(199602)29:2<165::AID-NEU4>3.0.CO;2-8 · DOI
- Larner, 1995, The cortical neuritic dystrophy of Alzheimer’s disease, Dementia, 6, 218
- Lassmann, 1992, Synaptic pathology in Alzheimer’s disease, Neuroscience, 46, 1, 10.1016/0306-4522(92)90003-K · DOI · Paper page
- Lewczuk, 1998, Prothrombin in normal human cerebrospinal fluid originates from the blood, Neurochem Res, 23, 1027, 10.1023/A:1020747716815 · DOI
- Mcarron, 1998, The apolipoprotein E epsilon 4 allele and outcome in cerebrovascular disease, Stroke, 29, 1882, 10.1161/01.STR.29.9.1882 · DOI
- Narindrasorasak, 1992, Characterization of high affinity binding between laminin and Alzheimer’s disease amyloid precursor proteins, Lab Invest, 67, 643
- Nitkin, 1987, Identification of agrin, a synaptic organizing protein from Torpedo electric organ, J Cell Biol, 105, 2471, 10.1083/jcb.105.6.2471 · DOI · Paper page
- O’Connor, 1994, Localization and alternative splicing of agrin mRNA in adult rat brain, J Neurosci, 14, 1141, 10.1523/JNEUROSCI.14-03-01141.1994 · DOI
- Perlmutter, 1991, Association between vascular basement membrane components and the lesions of Alzheimer’s disease, J Neurosci Res, 30, 673, 10.1002/jnr.490300411 · DOI
- Perlmutter, 1994, Microvascular pathology and vascular basement membrane components in Alzheimer’s disease, Mol Neurobiol, 9, 33, 10.1007/BF02816103 · DOI
- Perry, 1991, Association of heparan sulfate proteoglycan with the neurofibrillary tangles of Alzheimer’s disease, J Neurosci, 11, 3679, 10.1523/JNEUROSCI.11-11-03679.1991 · DOI · Paper page
- Reist, 1987, Agrin-like molecules at synaptic sites in normal, denervated, and damaged skeletal muscles, J Cell Biol, 105, 2457, 10.1083/jcb.105.6.2457 · DOI · Paper page
- Roses, 1996, The Alzheimer diseases, Curr Opin Neurobiol, 6, 644, 10.1016/S0959-4388(96)80098-5 · DOI
- Sims, 1983, Presynaptic cholinergic dysfunction in patients with dementia, J Neurochem, 40, 503, 10.1111/j.1471-4159.1983.tb11311.x · DOI · Paper page
- Small, 1994, A heparin-binding domain in the amyloid protein precursor of Alzheimer’s disease is involved in the regulation of neurite outgrowth, J Neurosci, 14, 2117, 10.1523/JNEUROSCI.14-04-02117.1994 · DOI · Paper page
- Small, 1996, The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer’s disease, Ann N Y Acad Sci, 777, 316, 10.1111/j.1749-6632.1996.tb34439.x · DOI
- Smith, 1987, Identification of agrin in electric organ extracts and localization of agrin-like molecules in muscle and central nervous system, J Exp Biol, 132, 223, 10.3181/00379727-132-34184 · doi:10.3181/00379727-132-34184
- Snow, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer’s disease, Am J Pathol, 133, 456
- Snow, 1994, An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain, Neuron, 12, 219, 10.1016/0896-6273(94)90165-1 · DOI · Paper page
- Tsen, 1995, Agrin is a heparan sulfate proteoglycan, J Biol Chem, 270, 3392, 10.1074/jbc.270.7.3392 · DOI · Paper page
- Wallace, 1989, Agrin-induced specializations contain cytoplasmic, membrane, and extracellular matrix-associated components of the postsynaptic apparatus, J Neurosci, 9, 1294, 10.1523/JNEUROSCI.09-04-01294.1989 · DOI · Paper page
- Zhang, 1992, c-fos protein-like immunoreactivity, Neuroscience, 46, 9, 10.1016/0306-4522(92)90004-L · DOI
Cited by
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Metadata
- Authors
- Berzin, T. M., Zipser, B. D., Rafii, M. S., Kuo—Leblanc, V., Yancopouloš, G. D., Glass, D. J., Fallon, J. R., & Stopa, E. G.
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 21
- Issue
- 2
- Pages
- 349-355
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2120334927
- Cited by
- 179
- References
- 5
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Agrin and microvascular damage in Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/s0197-4580(00)00121-4
- The paper
- Berzin, T. M., Zipser, B. D., Rafii, M. S., Kuo—Leblanc, V., Yancopouloš, G. D., Glass, D. J., Fallon, J. R., & Stopa, E. G. (2000). Agrin and microvascular damage in Alzheimer’s disease. Neurobiology of Aging. https://doi.org/10.1016/s0197-4580(00)00121-4
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.